πŸ‡ΊπŸ‡Έ FDA
Patent

US 10858436

PSGL-1 modulators and uses thereof

granted A61KA61K2039/505A61K48/00

Quick answer

US patent 10858436 (PSGL-1 modulators and uses thereof) held by SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE expires Mon Dec 03 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE
Grant date
Tue Dec 08 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 03 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
8
CPC classes
A61K, A61K2039/505, A61K48/00, A61P, A61P1/04